HU Faculty Publications - 1995 to Present Submit New Entry   
New Search
Display Publications of Faculty: Last name of author starts with "hill-williams" in All years

Hill-Williams, Karen (2000)
Specific Requirement for the p85-p110α Phosphatidylinositol 3- Kinase during Epidermal Growth Factor-stimulated Actin Nucleation in Breast Cancer Cells. J. Biol. Chem. 275 (2000): 3741 – 3744. Hill K., Welti S., Yu J., Murray J., Yip S.C., Condeelis J.S., Segall J.E., and Backer J. M.

Hill-Williams, Karen (2001)
N-Terminal Domains of the Class IA PI 3-Kinase Regulatory Subunit Play a Role in Cytoskeletal but not Mitogenic Signaling. J. Biol. Chem. 276 (2001): 16374 – 16378. Hill K., Huang Y., Yip J., Yu J., Segall J.E., and Backer J. M.

Hill-Williams, Karen (2001)
Comparative Pulmonary Toxicity of 6 Abrasive Blasting Agents. Toxicol. Sci. May; 61, No.1 (2001): 135 – 143. Hubbs S.F., Minhas NS., Jones W., Greskevitch M., Battelli LA., Porter DW., Goldsmith WT., Frazer D., Landsittel DP., Ma JY., Barger M., Hill K., Schwegler-Berry D., Robinson VA., and Castranova V.

Hill-Williams, Karen (2003)
Munc 18 Interacting (MINT) Proteins: Arf- dependent Coat Proteins that Regulate the Traffic of the Alzheimer’s Precursor Protein (β-APP). J. Biol. Chem. 278 (2003): 36032-36040. Hill K.,Li Y., Bennet M., McKay M., Zhu X., Shern J., Torre E., Lah JJ., Levey AL., and Kahn RA.

Hill-Williams, Karen (2004)
Over-expression of the p110β but not p110α Isoform of PI 3-Kinase Inhibits Motility in Breast Cancer Cells. Cell Motil. Cytoskeleton. 59, No.3 (2004): 180-188. Yip SC, El-Sibai M, Hill KM, Wu H, Fu Z, Condeelis JS, and Backer JM.

Hill-Williams, Karen (2005)
A distal regulatory region is required for constitutive IFN-beta-induced expression of murine TLR9. Journal of Immunology 175, No.11 (2005): 7407 -18. Guo Z. Garg S, Hill-Williams K, Jayashankar L, Hoelscher M, Boss J, Katz J, and Sambhara S.

Query: 0.017 seconds

Howard University. All rights reserved.
HOWARD UNIVERSITY LIBRARIES, 500 Howard Place, NW, Washington, DC 20059 - (202) 806-7234
Questions? Comments? - Contacts  - WWW Disclaimer